results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
Discussion & Analysis Q4/2021 Operating Highlights in Q4/2021 Q4/20 Q4/21 Change +/(-) 2020 2021 Change +/(-) (THB million) %YoY %YoY Operating Revenue 207 188 (9%) 768 620 (19%) Gross Profit 127 112 (12%) 468
Discussion & Analysis Q2/2022 Operating Highlights in Q4/2021 Q2/21 Q2/22 Change +/(-) 1H/21 1H/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 137 230 68% 317 428 35% Gross Profit 77 147 91% 183 267
Discussion & Analysis Q3/2022 Operating Highlights in Q3/2022 Q3/21 Q3/22 Change +/(-) 9M/21 9M/22 Change +/(-) (THB million) %YoY %YoY Operating Revenue 115 246 114% 431 674 56% Gross Profit 60 159 165% 242
Summary Significant Event Operating Highlights in Q3/2023 Q3/22 Q3/23 Change +/(-) 9M/22 9M/23 Change +/(-) (THB million) %YoY %YoY Operating Revenue 246 338 37% 674 900 34% Gross Profit 159 223 40% 426 583
Summary Significant Event Operating Highlights in Q4/2023 Q4/22 Q4/23 Change +/(-) 2022 2023 Change +/(-) (THB million) %YoY %YoY Operating Revenue 264 317 20% 938 1,217 30% Gross Profit 166 206 24% 592 789
conjunction with (11) and (12) of the first paragraph under Clause 12 and Clause 14 of the Notification of the Capital Market Supervisory Board No. Tor Thor. 35/2556 Re: Standard Conduct of Business, Management
customers and employees. The Group constantly monitors the situation to manage and mitigate risks, assess the impact on the business, and ensure that the operations comply with additional health and safety